[1]
Firmansyah, R.T. and Amalia, L.N. 2024. The Analysis Study of Effects of Glucagon-Like Peptide-1 Receptor to Reduce Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Comprehensive Systematic Review. The International Journal of Medical Science and Health Research. 4, 2 (Sep. 2024), 1–19. DOI:https://doi.org/10.70070/1qe6dr94.